Business Description
AstraZeneca PLC
NAICS : 325412
ISIN : GB0009895292
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.85 | |||||
Debt-to-EBITDA | 2.36 | |||||
Interest Coverage | 5.92 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.81 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | 14 | |||||
3-Year EPS without NRI Growth Rate | 37.2 | |||||
3-Year FCF Growth Rate | 38.8 | |||||
3-Year Book Growth Rate | 31.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 33.13 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.41 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 17.31 | |||||
9-Day RSI | 27.74 | |||||
14-Day RSI | 33.59 | |||||
6-1 Month Momentum % | -5.98 | |||||
12-1 Month Momentum % | 12.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.89 | |||||
Quick Ratio | 0.69 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 221.96 | |||||
Days Sales Outstanding | 78.67 | |||||
Days Payable | 694.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.02 | |||||
Dividend Payout Ratio | 0.64 | |||||
3-Year Dividend Growth Rate | 2.9 | |||||
Forward Dividend Yield % | 2.02 | |||||
5-Year Yield-on-Cost % | 2.15 | |||||
3-Year Average Share Buyback Ratio | -5.7 | |||||
Shareholder Yield % | 2.04 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 82.08 | |||||
Operating Margin % | 19.96 | |||||
Net Margin % | 13.1 | |||||
FCF Margin % | 14.28 | |||||
ROE % | 16.87 | |||||
ROA % | 6.43 | |||||
ROIC % | 9.53 | |||||
3-Year ROIIC % | 11.23 | |||||
ROC (Joel Greenblatt) % | 91.61 | |||||
ROCE % | 13.14 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 34.19 | |||||
Forward PE Ratio | 16.07 | |||||
PE Ratio without NRI | 31.34 | |||||
Shiller PE Ratio | 57.87 | |||||
Price-to-Owner-Earnings | 23.79 | |||||
PEG Ratio | 4.9 | |||||
PS Ratio | 4.5 | |||||
PB Ratio | 5.59 | |||||
Price-to-Free-Cash-Flow | 31.64 | |||||
Price-to-Operating-Cash-Flow | 19.94 | |||||
EV-to-EBIT | 26.07 | |||||
EV-to-Forward-EBIT | 15.82 | |||||
EV-to-EBITDA | 17.38 | |||||
EV-to-Forward-EBITDA | 12.93 | |||||
EV-to-Revenue | 4.98 | |||||
EV-to-Forward-Revenue | 4.6 | |||||
EV-to-FCF | 35.08 | |||||
Price-to-Projected-FCF | 2.68 | |||||
Price-to-DCF (Earnings Based) | 0.95 | |||||
Price-to-DCF (FCF Based) | 2.21 | |||||
Price-to-Median-PS-Value | 0.99 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.38 | |||||
Earnings Yield (Greenblatt) % | 3.84 | |||||
FCF Yield % | 3.18 | |||||
Forward Rate of Return (Yacktman) % | 11.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AstraZeneca PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 518,409.583 | ||
EPS (TTM) (kr) | 43.695 | ||
Beta | 0.82 | ||
Volatility % | 24.82 | ||
14-Day RSI | 33.59 | ||
14-Day ATR (kr) | 28.230964 | ||
20-Day SMA (kr) | 1609.025 | ||
12-1 Month Momentum % | 12.13 | ||
52-Week Range (kr) | 1261 - 1799 | ||
Shares Outstanding (Mil) | 1,550.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AstraZeneca PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AstraZeneca PLC Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
AstraZeneca PLC Frequently Asked Questions
What is AstraZeneca PLC(OSTO:AZN)'s stock price today?
When is next earnings date of AstraZeneca PLC(OSTO:AZN)?
Does AstraZeneca PLC(OSTO:AZN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |